Prognostic Role of Inflammatory Indices and Real-World Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine

<b><i>Background and Objectives:</i></b> Reliable pretreatment biomarkers to guide treatment selection in HER2-positive metastatic breast cancer (mBC) remain an unmet need. Systemic inflammatory indices derived from routine blood tests have emerged as accessible prognostic markers. This study evalua...

Descripción completa

Detalles Bibliográficos

Autores principales:	Taliha Güçlü Kantar, Tolga Doğan, Semra Taş, Bedriye Açıkgöz Yıldız, Gamze Serin Özel, Ceren Mordağ Çiçek, Ahmet Ali Kantar, Burcu Yapar Taşköylü, Atike Gökçen Demiray, Tarık Şengöz, Özgür Tanrıverdi, Arzu Yaren, Gamze Gököz Doğu
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2026-06-01
Colección:	Diagnostics
Materias:	T-DM1 HER2-positive metastatic breast cancer inflammatory indices neutrophil-to-lymphocyte ratio CRP/albumin ratio real-world outcomes
Acceso en línea:	https://www.mdpi.com/2075-4418/16/11/1746
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!